OCTAPHARMA AG

Company Overview

Since it was founded in 1983, the Swiss company Octapharma AG has grown into a truly global group. The company has more than 11,908 employees, serving patients in 118 countries. Octapharma AG is involved in the manufacture of therapeutic proteins. The company operates in hematology, immunohematology, and critical care, and it is considered one of the largest manufacturers of human proteins. Octapharma encourages plasma donation and sources approximately 80% of its plasma from donations owned by its 82 U.S. and 13 German plasma donation centers.

Octapharma Plasma Inc. operates FDA and EU approved plasma collection centers located throughout the U.S. The company is a subsidiary of Octapharma AG. Octapharma Plasma owns and operates plasma collection centers throughout the U.S. critical to the development of life-saving patient therapies utilized by thousands of patients all over the world.

Financial Highlights (FY 2023)

Company's Business Segments

• Human Protein Products : The company provides its product portfolio under three therapeutic areas such as haematology, immunotherapy, and critical care.